Evaluation of renal safety between Imipenem/Relebactam and Colistin Plus Imipenem in patients with Imipenem-nonsusceptible bacterial infections in the randomized, phase 3 RESTORE-IMI 1 study - Brown, Michelle L.; Motsch, Johann; Kaye, Keith S.; File, Thomas M.; Boucher, Helen W.; Vendetti, Neika; Aggrey, Angela; Joeng, Hee-Koung; Tipping, Robert W.; Du, Jiejun; DePestel, Daryl D.; Butterton, Joan R.; et al. (Open Forum Infectious Diseases, 2020)
Gesehen am 21.04.2020